ARS Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SPRY research report →
About the company
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings.
- CEO
- Richard E. Lowenthal
- IPO
- 2020
- Employees
- 155
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $850.04M
- P/E
- -4.26
- P/S
- 8.59
- P/B
- 13.86
- EV/EBITDA
- -4.80
- Div Yield
- 0.00%
- Gross Margin
- 77.10%
- Op Margin
- -204.49%
- Net Margin
- -200.00%
- ROE
- -153.61%
- ROIC
- -85.03%
- Revenue
- $84.28M · -5.46%
- Net Income
- $-171,298,000 · -2241.76%
- EPS
- $-1.74 · -2209.09%
- Op Income
- $-179,448,000
- FCF YoY
- -1418.48%
- 52W High
- $18.63
- 52W Low
- $6.66
- 50D MA
- $8.72
- 200D MA
- $9.32
- Beta
- 0.83
- Avg Volume
- 1.80M
Get TickerSpark's AI analysis on SPRY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | Casale Donn | other | 898,456 |
| Jun 24, 26 | RA CAPITAL MANAGEMENT, L.P. | other | 30,000 |
| Jun 24, 26 | Dadoo Rajeev | other | 30,000 |
| Jun 24, 26 | Shah Pratik | other | 30,000 |
| Jun 24, 26 | Kelly Michael | other | 30,000 |
| Jun 24, 26 | Islam Saqib | other | 30,000 |
| Jun 24, 26 | Thompson Peter A. | other | 30,000 |
| Jun 24, 26 | SAUNDERS BRENT L | other | 30,000 |
| Jun 24, 26 | SCHNEIDER PHILLIP M | other | 30,000 |
| Jun 24, 26 | Shawver Laura | other | 30,000 |
Our SPRY coverage
Recent articles, reports, and earnings notes.
No research on SPRY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SPRY report →Similar companies
Peers in the same neighborhood.